Surgery Partners Expects Fiscal Year 2024 Revenue To Be Greater Than $3B Versus Consensus Of $2.99B And Adjusted EBITDA To Be Greater than $495M
Portfolio Pulse from Benzinga Newsdesk
Surgery Partners projects its fiscal year 2024 revenue to exceed $3B, surpassing the consensus estimate of $2.99B. Additionally, the company anticipates its adjusted EBITDA to be greater than $495M.
February 26, 2024 | 12:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Surgery Partners expects its FY2024 revenue to surpass $3B, outdoing consensus estimates of $2.99B, and anticipates adjusted EBITDA over $495M.
The company's projection of exceeding revenue and EBITDA estimates for FY2024 suggests a positive outlook on its financial performance. This is likely to instill investor confidence and could lead to a short-term increase in stock price, given the higher than expected revenue and EBITDA figures.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100